Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors - PubMed https://t.co/dZexyuXCEr
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @KPSCalResearch: Researchers examined the risk of venous thromboembolism among breast cancer survivors. The study showed that aromatase…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
RT @bhwords: We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positiv…
We know tamoxifen use is associated with ⬆️ risk of venous thromboembolism (VTE). 12,900+ women with hormone- receptor positive breast cancer were followed for 5 yrs+. Those given aromatase inhibitor had a lower rate of VTE than tamoxifen use. https://t.co
RT @KPSCalResearch: Researchers examined the risk of venous thromboembolism among breast cancer survivors. The study showed that aromatase…
Researchers examined the risk of venous thromboembolism among breast cancer survivors. The study showed that aromatase inhibitors, a drug that combats breast cancer recurrence, did not increase VTE risk. #KPResearch in Breast Cancer Research and Treatment